UBS AM’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.09M Buy
233,675
+36,714
+19% +$485K ﹤0.01% 1702
2026
Q1
$3.24M Buy
196,961
+10,842
+6% +$266K ﹤0.01% 1796
2025
Q4
$5.32M Buy
186,119
+1,914
+1% +$51.9K ﹤0.01% 1435
2025
Q3
$5.42M Sell
184,205
-82,112
-31% -$2.24M ﹤0.01% 1334
2025
Q2
$7.68M Buy
266,317
+37,919
+17% +$1.12M ﹤0.01% 1488
2025
Q1
$7.99M Buy
228,398
+21,968
+11% +$896K ﹤0.01% 1333
2024
Q4
$9.2M Buy
206,430
+48,846
+31% +$2M ﹤0.01% 1290
2024
Q3
$7.19M Buy
157,584
+2,385
+2% +$96.5K ﹤0.01% 1381
2024
Q2
$5.16M Buy
155,199
+53,851
+53% +$2.2M ﹤0.01% 1462
2024
Q1
$4.86M Buy
101,348
+8,471
+9% +$494K ﹤0.01% 1268
2023
Q4
$6.85M Buy
92,877
+800
+0.9% +$54.1K ﹤0.01% 1128
2023
Q3
$6.73M Buy
92,077
+145
+0.2% +$11.6K ﹤0.01% 1107
2023
Q2
$8.19M Hold
91,932
﹤0.01% 1040
2023
Q1
$8.19M Buy
91,932
+6,100
+7% +$531K ﹤0.01% 1040
2022
Q4
$7.35M Buy
85,832
+2,148
+3% +$182K ﹤0.01% 1046
2022
Q3
$5.98M Sell
83,684
-16,801
-17% -$1.5M ﹤0.01% 1140
2022
Q2
$9.77M Buy
100,485
+29,605
+42% +$3.02M 0.01% 966
2022
Q1
$7.97M Buy
70,880
+2,882
+4% +$307K ﹤0.01% 1162
2021
Q4
$9.18M Buy
67,998
+970
+1% +$135K ﹤0.01% 1158
2021
Q3
$9.46M Buy
67,028
+2,165
+3% +$291K ﹤0.01% 1113
2021
Q2
$8.31M Buy
64,863
+3,015
+5% +$355K ﹤0.01% 1182
2021
Q1
$7.91M Sell
61,848
-955
-2% -$176K ﹤0.01% 1159
2020
Q4
$11.3M Buy
62,803
+7,430
+13% +$1.65M 0.01% 1016
2020
Q3
$12.1M Buy
55,373
+3,557
+7% +$794K 0.01% 889
2020
Q2
$11.6M Buy
51,816
+14,513
+39% +$2.27M 0.01% 867
2020
Q1
$3.65M Sell
37,303
-452
-1% -$36.6K ﹤0.01% 1172
2019
Q4
$2.83M Buy
37,755
+2,719
+8% +$176K ﹤0.01% 1447
2019
Q3
$2.15M Buy
35,036
+9,344
+36% +$562K ﹤0.01% 1589
2019
Q2
$1.52M Buy
25,692
+1,742
+7% +$104K ﹤0.01% 1721
2019
Q1
$1.57M Buy
23,950
+6,512
+37% +$394K ﹤0.01% 1636
2018
Q4
$851K Sell
17,438
-1,719
-9% -$103K ﹤0.01% 1818
2018
Q3
$1.25M Buy
19,157
+3,070
+19% +$215K ﹤0.01% 1720
2018
Q2
$1.07M Buy
16,087
+2,947
+22% +$178K ﹤0.01% 1795
2018
Q1
$681K Hold
13,140
﹤0.01% 1906
2017
Q4
$570K Buy
13,140
+8,341
+174% +$341K ﹤0.01% 1928
2017
Q3
$210K Buy
+4,799
New +$167K ﹤0.01% 2238
2016
Q4
Sell
-13,699
Closed -$303K 2619
2016
Q3
$303K Hold
13,699
﹤0.01% 2260
2016
Q2
$245K Hold
13,699
﹤0.01% 2329
2016
Q1
$236K Sell
13,699
-1,000
-7% -$16.7K ﹤0.01% 2346
2015
Q4
$312K Hold
14,699
﹤0.01% 2319
2015
Q3
$278K Hold
14,699
﹤0.01% 2323
2015
Q2
$337K Buy
14,699
+400
+3% +$9.31K ﹤0.01% 2294
2015
Q1
$386K Buy
14,299
+2,400
+20% +$61.2K ﹤0.01% 2116
2014
Q4
$344K Hold
11,899
﹤0.01% 2142
2014
Q3
$320K Hold
11,899
﹤0.01% 2112
2014
Q2
$263K Hold
11,899
﹤0.01% 2260
2014
Q1
$325K Buy
11,899
+900
+8% +$26.3K ﹤0.01% 2135
2013
Q4
$340K Sell
10,999
-1,200
-10% -$30.8K ﹤0.01% 2038
2013
Q3
$346K Sell
12,199
-1,700
-12% -$46.4K ﹤0.01% 1996
2013
Q2
$355K Buy
+13,899
New +$326K ﹤0.01% 1886

Other funds holding QDEL

UBS AM's QDEL Position: Q2 2026 in Review

UBS AM increased its QuidelOrtho (QDEL) stake by 19% in Q2 2026, buying an estimated $485K and bringing the position to 233,675 shares worth $4.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

UBS AM first reported a position in QDEL in Q2 2013 and has held it in 50 quarters since. The position peaked at $12.1M in Q3 2020. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • UBS AM held 233,675 shares of QuidelOrtho worth $4.09M as of Q2 2026.
  • UBS AM bought 36,714 QuidelOrtho shares in Q2 2026, an estimated $485K.
  • QuidelOrtho made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1702 holding.
  • UBS AM first reported a position in QuidelOrtho in Q2 2013 and has held it in 50 quarters since.
  • UBS AM's QuidelOrtho position peaked at $12.1M in Q3 2020.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.